Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human MAPK14 Antibodies:
anti-Mouse (Murine) MAPK14 Antibodies:
anti-Rat (Rattus) MAPK14 Antibodies:
Go to our pre-filtered search.
Human Polyclonal MAPK14 Primary Antibody for FACS, IF - ABIN1882176
Cheung, Campbell, Nebreda, Cohen: Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. in The EMBO journal 2003
Show all 7 Pubmed References
Dog (Canine) Monoclonal MAPK14 Primary Antibody for IF, WB - ABIN968769
Brunet, Pouysségur: Identification of MAP kinase domains by redirecting stress signals into growth factor responses. in Science (New York, N.Y.) 1996
Show all 4 Pubmed References
Dog (Canine) Monoclonal MAPK14 Primary Antibody for IF, WB - ABIN968770
Han, Lee, Bibbs, Ulevitch: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. in Science (New York, N.Y.) 1994
Show all 4 Pubmed References
Human Monoclonal MAPK14 Primary Antibody for ICC, FACS - ABIN1724830
Li, Zheng, Li, Ma: Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-?B activation on endothelial cell. in Cytokine 2012
Show all 2 Pubmed References
Human Monoclonal MAPK14 Primary Antibody for IHC, ELISA - ABIN1724904
Chung, Tang, Sun, Chou, Yeh, Yu, Sun: Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. in Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Show all 2 Pubmed References
results suggest that ET-1 (show EDN1 Antibodies)-induced activation of proMMP-2 is mediated via cross-talk between NADPH oxidase (show NOX1 Antibodies)-PKCalpha (show PKCa Antibodies)-p(38)MAPK (show MAPK1 Antibodies) and NFkappaB-MT1MMP (show MMP14 Antibodies) signaling pathways along with a marked decrease in TIMP-2 (show TIMP2 Antibodies) expression in the cells
cross-talk between p(38)MAPK (show MAPK1 Antibodies) and Gialpha play a pivotal role for full activation of cPLA2 (show PLA2G4A Antibodies) during ET-1 (show EDN1 Antibodies) stimulation of pulmonary artery smooth muscle cells.
MAPK14 signalling pathway is largely involved in heat-induced sperm damage.
p38 MAPK is an early redox sensor in the laminar shear stress with hydrogen peroxide being a signaling mediator.
Blockade of p38 enhances chondrocyte phenotype in monolayer culture and may promote more efficient cartilage tissue regeneration for cell-based therapies.
p38 phosphorylation and MMP13 (show MMP13 Antibodies) expression are regulated by Rho/ROCK activation, and support the potential novel pathway that Rho/ROCK is in the upper part of the mechanical stress-induced matrix degeneration cascade in cartilage.
These data suggest that the p38 and JNK (show MAPK8 Antibodies) signaling pathways play pivotal roles in PRRSV replication and may regulate immune responses during virus infection.
findings support the hypothesis that ischemic factor stimulation of the blood-brain barrier Na-K-Cl cotransporter (show SLC12A1 Antibodies) involves activation of p38 and JNK (show MAPK8 Antibodies) MAPKs
These data suggest a differential requirement of JNK1 (show MAPK8 Antibodies) and p38 MAPK in TNF (show TNF Antibodies) regulation of E2F1 (show E2F1 Antibodies). Targeted inactivation of JNK1 (show MAPK8 Antibodies) at arterial injury sites may represent a potential therapeutic intervention for ameliorating TNF (show TNF Antibodies)-mediated EC dysfunction.
p38 MAPK (MAPK14) is redox-regulated in reactive oxygen species-dependent endothelial barrier dysfunction.
ROS (show ROS1 Antibodies)/JNK (show MAPK8 Antibodies)/p38/Upd (show UROD Antibodies) stress responsive module restores tissue homeostasis. This module is not only activated after cell death induction but also after physical damage and reveals one of the earliest responses for imaginal disc regeneration.
Taken together, our findings indicate that the p38 MAP Kinase is an integral component of the core circadian clock of Drosophila in addition to playing a role in stress-input pathways.
Data show that the genetic interaction between p38b MAPK (show MAPK1 Antibodies) and Rack1 (show GNB2L1 Antibodies) controls muscle aggregate formation, locomotor function, and longevity.
The interaction of any of several Drosophila Delta class glutathione transferases and p38b mitogen-activated protein kinase (show MAPK1 Antibodies) can affect the substrate specificity of either enzyme, which suggests induced conformational changes affecting catalysis.
found a correlation between the depth of integration of individual p38 kinases into the protein interaction network and their functional significance; propose a central role of p38b in the p38 signaling module with p38a and p38c playing more peripheral auxiliary roles
Loss of p38 MAPK causes early lethality and precipitates age-related motor dysfunction and stress sensitivity.
The p38 pathway-mediated stress response contribute to Drosophila host defense against microbial infection.
p38b MAPK (show MAPK1 Antibodies) plays a crucial role in the balance between intestinal stem cell proliferation and proper differentiation in the adult Drosophila midgut.
the D-p38b gene is regulated by the DREF (show ZBED1 Antibodies) pathway and DREF (show ZBED1 Antibodies) is involved in the regulation of proliferation and differentiation of Drosophila ISCs (show NFS1 Antibodies) and progenitors
p38 mitogen-activated protein kinase is crucial for bovine papillomavirus type-1 transformation of equine fibroblasts.
p38 Mitogen-activated protein kinase (MAPK (show MAPK1 Antibodies)) is essential for drug-induced COX-2 (show PTGS2 Antibodies) expression in leukocytes, suggesting that p38 MAPK is a potential target for anti-inflammatory therapy.
These findings support a function for p38 MAPK in equine neutrophil migration and suggest the potential for the ability of p38 MAPK inhibition to limit neutrophilic inflammation in the laminae during acute laminitis.
Cultured equine digital vein endothelial cells were exposed to lipopolysaccharide and phosphorylation of p38 MAPK was assessed by Western blotting using phospho-specific antibodies.
our results strongly indicate that the crosstalk between p38 (show CRK Antibodies) and Akt (show AKT1 Antibodies) pathways can determine special AT-rich sequence-binding protein 2 (show SATB2 Antibodies) expression and epithelial character of non-small-cell lung carcinoma cells
Osmotic stress promotes TEAD4 (show TEAD4 Antibodies) cytoplasmic translocation via p38 MAPK in a Hippo-independent manner. Stress-induced TEAD inhibition predominates YAP (show YAP1 Antibodies)-activating signals and selectively suppresses YAP (show YAP1 Antibodies)-driven cancer cell growth.
TGF-beta (show TGFB1 Antibodies) induces p38alpha (mitogen-activated protein kinase 14 [MAPK14]), which in turn phosphorylates NR4A1 (show NR4A1 Antibodies), resulting in nuclear export of the receptor.
Data suggest that suppression of nonsense-mediated RNA decay due to persistent DNA damage (from exposure to either mutagens, gamma rays, or oxidative stress) requires the activity of p38alpha MAPK (show MAPK1 Antibodies) (MAPK14, mitogen-activated protein kinase 14, MAP kinase p38 alpha); mRNA of ATF3 (activating transcription factor 3 (show ATF3 Antibodies)) is stabilized by persistent DNA damage in a p38alpha MAPK (show MAPK1 Antibodies)-dependent manner.
VEGF (show VEGFA Antibodies)-activated p38alpha phosphorylates coronin 1B (show CORO1B Antibodies) at Ser2 (show JAG2 Antibodies) and activates the Arp2 (show ACTR2 Antibodies)/3 complex by liberating it from coronin 1B (show CORO1B Antibodies).
findings show that endothelial MAPKs ERK (show EPHB2 Antibodies), p38 (show CRK Antibodies), and JNK (show MAPK8 Antibodies) mediate diapedesis-related and diapedesis-unrelated functions of ICAM-1 (show ICAM1 Antibodies) in cerebral and dermal microvascular endothelial cells
Tetraarsenic hexoxide (As4O6) induced G2/M arrest, apoptosis and autophagic cell death through PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) and p38 MAPK pathways alteration in SW620 colon cancer cells.
The N-Terminal phosphorylation of RB by p38 (show CRK Antibodies) bypasses its inactivation by cyclin (show PCNA Antibodies)-dependent kinases and prevents proliferation in cancer cells.
Inhibition of MAPK14 conclusively facilitates elucidation of the impact of the complex network of p38 MAPK signaling on atherogenesis.
Collectively, this study provides more insights into RELT (show RELT Antibodies) expression, RELT (show RELT Antibodies) family member function, and the mechanism of RELT (show RELT Antibodies)-induced death.
Data suggest that Mapk14/p38alpha is activated and forms cystine disulfide-bound heterodimer with Map2k3/Mkk3 (show MAP2K3 Antibodies) in cardiomyocytes and isolated hearts during oxidative stress. (Mapk14, mitogen-activated protein kinase 14; Mkk3 (show MAP2K3 Antibodies) = mitogen-activated protein kinase kinase 3 (show MAP2K3 Antibodies))
High-glucose induces tau hyperphosphorylation through activation of TLR9 (show TLR9 Antibodies)-P38 MAPK pathway.
Doxorubicin (Dox)-administration to cardiomyocytes increased the levels of reactive oxygen species (ROS (show ROS1 Antibodies)) in a time-dependent manner that followed the activation of stress-induced proteins p53 (show TP53 Antibodies), p38 (show CRK Antibodies) and JNK (show MAPK8 Antibodies) MAPKs, culminating in an increase in autophagy and apoptosis markers.
Soluble epoxide hydrolase (show EPHX2 Antibodies) inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38 (show CRK Antibodies)/Smad3 (show SMAD3 Antibodies) signaling pathway.
These results provide evidence supporting a key role for the p38 MAPK signaling pathway which is involved in the regulation of Abeta1-42 internalization in the parietal cortex and hippocampus of mouse through LRP1 (show LRP1 Antibodies) in vivo.
Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting were used to detect the mRNA and protein expressions of p-p38MAPK, AAT (show SERPINA1A Antibodies), signal transducer and activator of transcription 1 (STAT1 (show STAT1 Antibodies)) and activating transcription factor2 (ATF2 (show ATF2 Antibodies))
p38alpha is essential to maintain in actin dynamics with age in hepatocytes.
Data, including data from studies conducted in cells from transgenic/knockout mice, suggest that p38alpha MAPK (show MAPK1 Antibodies) (Mapk14) activity is required for hypoxia-induced pro-angiogenic activity involving cardiomyocytes and vascular endothelial cells; p38 MAPK activation in cardiomyocyte is sufficient to promote paracrine signaling-mediated, pro-angiogenic activity/myocardial revascularization.
blockage of NF-kappaB (show NFKB1 Antibodies) p65 (show NFkBP65 Antibodies) and/or MAPK p38 (show MAPK1 Antibodies) with their specific inhibitors strongly attenuated B7-H3 (show CD276 Antibodies)-amplified inflammatory response with significantly reduced proinflammatory cytokine and chemokine (show CCL1 Antibodies) production, and markedly ameliorated B7-H3 (show CD276 Antibodies)-exacerbated disruption of blood-brain barrier and severity of disease status in S. pneumoniae-infected mice.
These findings suggest that the TQ-induced production of ROS (show ROS1 Antibodies) causes dedifferentiation through the ERK (show MAPK1 Antibodies) pathway and inflammation through the PI3K and p38 pathways in rabbit articular chondrocytes.
These results suggest that p38 MAPK signal transduction pathway is critical to NO-induced chondrocyte apoptosis, and p38 plays a role by way of stimulating NF-kappaB (show NFKB1 Antibodies), p53 (show TP53 Antibodies) and caspase-3 (show CASP3 Antibodies) activation.
Porcine reproductive and respiratory syndrome virus strain CH-1a could significantly up-regulate IL-10 (show IL10 Antibodies) production through p38 MAPK activation.
JNK (show MAPK8 Antibodies) plays an active role in fragmentation of pig oocytes and p38 MAPK is not involved in this process.[p38MAPK]
Retinal ischemia-reperfusion alters expression of mitogen-activated protein kinases, particularly ERK1/2 (show MAPK1/3 Antibodies), in the neuroretina and retinal arteries.
cytochrome c (show CYCS Antibodies) microinjection induces p38 phosphorylation through caspase-3 (show CASP3 Antibodies) activation, and caspase (show CASP3 Antibodies) inhibition reduces p38 activation induced by osmostress, indicating that a positive feedback loop is engaged by hyperosmotic shock
The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.
MAP kinase 14
, MAP kinase p38 alpha
, MAPK 14
, mitogen-activated protein kinase p38 alpha
, p38 mitogen activated protein kinase
, p38 mitogen-activated protein kinase
, stress-activated p38b MAP kinase
, p38 mitogen-activated kinase
, cytokine suppressive anti-inflammatory drug binding protein 1
, mitogen activated protein kinase 14
, p38 MAP kinase alpha
, p38 MAPK
, p38 alpha
, tRNA synthetase cofactor p38
, CSAIDS-binding protein 1
, mitogen-activated protein kinase 14A
, stress-activated protein kinase 2a
, Csaids binding protein
, MAP kinase 2
, MAP kinase Mxi2
, MAX-interacting protein 2
, cytokine suppressive anti-inflammatory drug binding protein
, cytokine-supressive anti-inflammatory drug binding protein
, mitogen-activated protein kinase 14
, p38 MAP kinase
, p38alpha Exip
, reactive kinase
, stress-activated protein kinase 2A
, MAPK p38
, Mitogen-activated protein kinase 2
, mitogen-activated Mitogen-activated protein kinase 2